Literature DB >> 16122996

A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis.

Polly J Ferguson1, Xinyu Bing, Mohammed A Vasef, Luis A Ochoa, Amar Mahgoub, Thomas J Waldschmidt, Lorraine T Tygrett, Annette J Schlueter, Hatem El-Shanti.   

Abstract

Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory disorder that primarily affects bone but is often accompanied by inflammation of the skin and/or gastrointestinal tract. The etiology is unknown but evidence suggests a genetic component to disease susceptibility. Although most cases of CRMO are sporadic, there is an autosomal recessive syndromic form of the disease, called Majeed syndrome, which is due to homozygous mutations in LPIN2. In addition, there is a phenotypically similar mouse, called cmo (chronic multifocal osteomyelitis) in which the disease is inherited as an autosomal recessive disorder. The cmo locus has been mapped to murine chromosome 18. In this report, we describe phenotypic abnormalities in the cmo mouse that include bone, cartilage and skin inflammation. Utilizing a backcross breeding strategy, we refined the cmo locus to a 1.3 Mb region on murine chromosome 18. Within the refined region was the gene pstpip2, which shares significant sequence homology to the PSTPIP1. Mutations in PSTPIP1 have been shown to cause the autoinflammatory disorder PAPA syndrome (pyogenic arthritis, pyoderma gangrenosum and acne). Mutation analysis, utilizing direct sequencing, revealed a single base pair change c.293T --> C in the pstpip2 gene resulting in a highly conserved leucine at amino acid 98 being replaced by a proline (L98P). No other mutations were found in the coding sequence of the remaining genes in the refined interval, although a 50 kb gap remains unexplored. These data suggest that mutations in pstpip2 may be the genetic explanation for the autoinflammatory phenotype seen in the cmo mouse.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122996      PMCID: PMC3726202          DOI: 10.1016/j.bone.2005.07.009

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  31 in total

1.  Chronic recurrent multifocal osteomyelitis associated with ulcerative colitis: a case report.

Authors:  A Bazrafshan; K S Zanjani
Journal:  J Pediatr Surg       Date:  2000-10       Impact factor: 2.545

2.  On mice and men: An autosomal recessive syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia.

Authors:  H A Majeed; H El-Shanti; H Al-Rimawi; N Al-Masri
Journal:  J Pediatr       Date:  2000-09       Impact factor: 4.406

3.  Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children.

Authors:  A Bousvaros; M Marcon; W Treem; P Waters; R Issenman; R Couper; R Burnell; A Rosenberg; E Rabinovich; B S Kirschner
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

4.  Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term.

Authors:  O Vittecoq; L A Said; C Michot; O Mejjad; J M Thomine; P Mitrofanoff; J Lechevallier; P Ledosseur; A Gayet; P Lauret; X le Loët
Journal:  Arthritis Rheum       Date:  2000-01

5.  [Subacute and chronic "symmetrical" osteomyelitis].

Authors:  A Giedion; W Holthusen; L F Masel; D Vischer
Journal:  Ann Radiol (Paris)       Date:  1972 Mar-Apr

6.  Recurrent hyperostosis of the clavicles: an undiagnosed syndrome.

Authors:  J A Keipert; P E Campbell
Journal:  Aust Paediatr J       Date:  1970-03

7.  The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review.

Authors:  H A Majeed; M Al-Tarawna; H El-Shanti; B Kamel; F Al-Khalaileh
Journal:  Eur J Pediatr       Date:  2001-12       Impact factor: 3.183

8.  Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22.

Authors:  Astrid Golla; Annette Jansson; Juliane Ramser; Heide Hellebrand; Robert Zahn; Thomas Meitinger; Bernd H Belohradsky; Alfons Meindl
Journal:  Eur J Hum Genet       Date:  2002-03       Impact factor: 4.246

9.  Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder.

Authors:  Carol A Wise; Joseph D Gillum; Christine E Seidman; Noralane M Lindor; Rose Veile; Stavros Bashiardes; Michael Lovett
Journal:  Hum Mol Genet       Date:  2002-04-15       Impact factor: 6.150

10.  Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway.

Authors:  Nitza G Shoham; Michael Centola; Elizabeth Mansfield; Keith M Hull; Geryl Wood; Carol A Wise; Daniel L Kastner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

View more
  69 in total

1.  BAR proteins in cancer and blood disorders.

Authors:  Yolande Chen; Jorie Aardema; Ashish Misra; Seth J Corey
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 2.  Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

Authors:  R Goldbach-Mansky
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

3.  Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease.

Authors:  Johannes Grosse; Violeta Chitu; Andreas Marquardt; Petra Hanke; Carolin Schmittwolf; Lutz Zeitlmann; Patricia Schropp; Bettina Barth; Philipp Yu; Rainer Paffenholz; Gabriele Stumm; Michael Nehls; E Richard Stanley
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

Review 4.  An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children.

Authors:  Andrea Taddio; Floriana Zennaro; Serena Pastore; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

5.  An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.

Authors:  Ivona Aksentijevich; Seth L Masters; Polly J Ferguson; Paul Dancey; Joost Frenkel; Annet van Royen-Kerkhoff; Ron Laxer; Ulf Tedgård; Edward W Cowen; Tuyet-Hang Pham; Matthew Booty; Jacob D Estes; Netanya G Sandler; Nicole Plass; Deborah L Stone; Maria L Turner; Suvimol Hill; John A Butman; Rayfel Schneider; Paul Babyn; Hatem I El-Shanti; Elena Pope; Karyl Barron; Xinyu Bing; Arian Laurence; Chyi-Chia R Lee; Dawn Chapelle; Gillian I Clarke; Kamal Ohson; Marc Nicholson; Massimo Gadina; Barbara Yang; Benjamin D Korman; Peter K Gregersen; P Martin van Hagen; A Elisabeth Hak; Marjan Huizing; Proton Rahman; Daniel C Douek; Elaine F Remmers; Daniel L Kastner; Raphaela Goldbach-Mansky
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

Review 6.  SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.

Authors:  Davide Firinu; Vanessa Garcia-Larsen; Paolo Emilio Manconi; Stefano R Del Giacco
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 7.  New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome.

Authors:  Marina Magrey; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

8.  Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice.

Authors:  Violeta Chitu; Polly J Ferguson; Rosalie de Bruijn; Annette J Schlueter; Luis A Ochoa; Thomas J Waldschmidt; Yee-Guide Yeung; E Richard Stanley
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

Review 9.  The spectrum of autoinflammatory diseases: recent bench to bedside observations.

Authors:  John G Ryan; Raphaela Goldbach-Mansky
Journal:  Curr Opin Rheumatol       Date:  2008-01       Impact factor: 5.006

10.  Pyrin Modulates the Intracellular Distribution of PSTPIP1.

Authors:  Andrea L Waite; Philip Schaner; Neil Richards; Banu Balci-Peynircioglu; Seth L Masters; Susannah D Brydges; Michelle Fox; Arthur Hong; Engin Yilmaz; Daniel L Kastner; Ellis L Reinherz; Deborah L Gumucio
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.